Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diagnostic imaging encompasses a wide array of non-invasive technologies, such as X-ray, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), positron emission tomography (PET), and others, which allow physicians to obtain visual representations of internal body structures and functions[1][3][5][7][9]. These tools are essential in modern medicine for disease detection, diagnosis, monitoring, and guiding treatments. While diagnostic imaging can use contrast agents or radiotracers that interact with biological tissues, "diagnostic imaging" itself is not a molecular target, but rather a category of technologies that visualize anatomical and sometimes functional or molecular processes. In summary: "Diagnostic imaging" is not a molecular target but refers to clinical imaging technologies and modalities. The use of this term as a therapeutic target is incorrect, and structured information relevant to molecular or receptor-based drug targeting does not apply.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diagnostic imaging (None).